These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22095793)

  • 61. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
    Morley KC; Leung S; Baillie A; Haber PS
    Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of alcoholic liver disease among Korean adults: results from the fourth Korea National Health and Nutrition Examination Survey, 2009.
    Park SH; Kim CH; Kim DJ; Park JH; Kim TO; Yang SY; Moon YS; Kim TN; Kim HK; Park HY; Lee JG; Lee HY
    Subst Use Misuse; 2011; 46(14):1755-62. PubMed ID: 21999409
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A new approach to drug therapy in non-alcoholic steatohepatitis (NASH).
    Fehér J; Lengyel G
    J Int Med Res; 2003; 31(6):537-51. PubMed ID: 14708419
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic.
    Owens L; Thompson A; Rose A; Gilmore I; Pirmohamed M; Richardson P
    Alcohol; 2017 Aug; 62():11-15. PubMed ID: 28755747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence.
    García ML; Blasco-Algora S; Fernández-Rodríguez CM
    World J Gastroenterol; 2015 Jul; 21(28):8516-26. PubMed ID: 26229395
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of alcohol dependence in patients with liver disease.
    Addolorato G; Mirijello A; Leggio L; Ferrulli A; Landolfi R
    CNS Drugs; 2013 Apr; 27(4):287-99. PubMed ID: 23456576
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program.
    Kirpich IA; McClain CJ; Vatsalya V; Schwandt M; Phillips M; Falkner KC; Zhang L; Harwell C; George DT; Umhau JC
    Alcohol Clin Exp Res; 2017 Apr; 41(4):747-757. PubMed ID: 28166367
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Improvement of the complex medical treatment for the patients wіth chronic biliary pancreatitis.
    Babinets LS; Kytsai KY; Kotsaba YY; Halabitska IM; Melnyk NA; Semenova IV; Zemlyak OS
    Wiad Lek; 2017; 70(2):213-216. PubMed ID: 28511162
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacotherapy for alcoholic patients with alcoholic liver disease.
    Vuittonet CL; Halse M; Leggio L; Fricchione SB; Brickley M; Haass-Koffler CL; Tavares T; Swift RM; Kenna GA
    Am J Health Syst Pharm; 2014 Aug; 71(15):1265-76. PubMed ID: 25027533
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pyridoxol L,2-pyrrolidon-5 carboxylate prevents active fibroplasia in CCl4-treated rats.
    Annoni G; Contu L; Tronci MA; Caputo A; Arosio B
    Pharmacol Res; 1992 Jan; 25(1):87-93. PubMed ID: 1310810
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation.
    Rolland B; Labreuche J; Duhamel A; Deheul S; Gautier S; Auffret M; Pignon B; Valin T; Bordet R; Cottencin O
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1631-6. PubMed ID: 26095229
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacotherapy of alcoholic liver disease in clinical practice.
    Rosato V; Abenavoli L; Federico A; Masarone M; Persico M
    Int J Clin Pract; 2016 Feb; 70(2):119-31. PubMed ID: 26709723
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Correction of metabolic disorders during treatment of alcohol-induced liver injuries in patients with acute alcoholic intoxication].
    Shilov VV; Shikalova IA; Vasil'ev SA; Batotsyrenov BV; Andrianov AIu
    Klin Med (Mosk); 2013; 91(2):45-8. PubMed ID: 23718065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Severe alcohol-induced liver disease and the alcohol dependence syndrome.
    Smith S; White J; Nelson C; Davies M; Lavers J; Sheron N
    Alcohol Alcohol; 2006; 41(3):274-7. PubMed ID: 16522743
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alcohol Use Disorders in Alcoholic Liver Disease.
    Mellinger JL; Winder GS
    Clin Liver Dis; 2019 Feb; 23(1):55-69. PubMed ID: 30454833
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adolescent Alcoholic Liver Disease.
    Taylor SA; Miloh T
    Clin Liver Dis; 2019 Feb; 23(1):51-54. PubMed ID: 30454832
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alcohol-related liver disease: Time for action.
    Bataller R; Arteel GE; Moreno C; Shah V
    J Hepatol; 2019 Feb; 70(2):221-222. PubMed ID: 30658723
    [No Abstract]   [Full Text] [Related]  

  • 78. Alcoholic liver disease: a clinical series in an Australian private practice.
    Hourigan KJ; Bowling FG
    J Gastroenterol Hepatol; 2001 Oct; 16(10):1138-43. PubMed ID: 11686841
    [TBL] [Abstract][Full Text] [Related]  

  • 79. N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research.
    Morley KC; Baillie A; Van Den Brink W; Chitty KE; Brady K; Back SE; Seth D; Sutherland G; Leggio L; Haber PS
    Expert Opin Investig Drugs; 2018 Aug; 27(8):667-675. PubMed ID: 30019966
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Hepatic damage caused by drugs and evaluation of the therapeutic effectiveness of pyridoxine pyrrolidone carboxylate].
    Nami R
    Clin Ter; 1979 Oct; 91(1):41-55. PubMed ID: 546575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.